Log In
Print
BCIQ
Print
Print this Print this
 

Ryanodex, dantrolene (EP-4104)

  Manage Alerts
Collapse Summary General Information
Company Eagle Pharmaceuticals Inc.
DescriptionLyophilized formulation of dantrolene, a sodium muscle relaxant
Molecular Target Ryanodine receptor 1 (RyR1)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard Indication Metabolic (unspecified)
Indication DetailsTreat exertional heat stroke; Treat malignant hyperthermia
Regulatory Designation

U.S. - Orphan Drug (Treat malignant hyperthermia);
U.S. - Priority Review (Treat malignant hyperthermia)

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today